Veracyte VCYT Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $139.07M+21.5% | $140.64M+18.5% | $131.87M+13.8% | $130.16M+13.8% | $114.47M+18.2% | ||
| —— | —— | —— | —— | —— | ||
| $101.16M+27.2% | $101.97M+29.5% | $91.28M+15.5% | $89.77M+15.2% | $79.51M+27.3% | ||
| 72.7%+3.3pp | 72.5%+6.1pp | 69.2%+1.0pp | 69%+0.9pp | 69.5%+5.0pp | ||
| $27.1M+52.9% | $20.85M+8.1% | $15.98M-9.1% | $16.26M-1.2% | $17.72M+11.0% | ||
| $27.16M+11.0% | $25.94M+4.5% | $24.46M+8.2% | $25.32M+4.5% | $24.45M+2.8% | ||
| $23.68M-30.0% | $17.37M-35.5% | $27.28M+6.0% | $32.33M+1.8% | $33.81M+29.0% | ||
| $5.43M+1.3% | $5.3M-15.3% | $5.27M-10.4% | $5.49M-4.3% | $5.36M+46.8% | ||
| —— | —— | —— | —— | —— | ||
| $78.51M+2.5% | $64.78M-13.1% | $68.34M+2.0% | $95.04M+29.6% | $76.6M+14.1% | ||
| $22.65M+680% | $37.2M+791% | $22.95M+90.9% | -$5.27M-214% | $2.9M+162% | ||
| 16.3%+13.7pp | 26.4%+22.9pp | 17.4%+7.0pp | -4%-8.1pp | 2.5%+7.3pp | ||
| $7.33M+62.0% | $3.44M— | -$4.06M-184% | $6.52M+137% | $4.52M+64.6% | ||
| $29.97M+304% | $40.63M+1,080% | $18.89M+12.1% | $1.25M-83.0% | $7.43M+489% | ||
| $1.27M+233% | —— | -$248K-115% | $2.23M+37.1% | $381K+966% | ||
| $28.71M+307% | $41.15M+705% | $19.14M+26.3% | -$980K-117% | $7.05M+478% | ||
| 20.6%+14.5pp | 29.3%+24.9pp | 14.5%+1.4pp | -0.8%-5.8pp | 6.2%+8.1pp | ||
| $0.35+289% | $0.50+733% | $0.24+26.3% | -$0.01-114% | $0.09+550% | ||
| $0.36+300% | $0.52+643% | $0.24+20.0% | -$0.01-114% | $0.09+550% | ||
| 81.3M+1.6% | 80.6M+3.1% | 79.7M+1.6% | 78.4M+1.6% | 80.1M+7.1% | ||
| 79.5M+1.9% | 78.6M+2.7% | 78.7M+2.2% | 78.4M+2.4% | 78M+4.4% | ||
| $2.71M+4.7% | $2.71M-3.7% | $2.71M-7.2% | $2.67M-8.3% | $2.59M-11.3% | ||
| $37.91M+8.4% | $38.66M-3.0% | $40.59M+10.1% | $40.4M+10.6% | $34.97M+1.7% | ||
| $7.33M+62.0% | $3.44M— | -$4.06M-184% | $6.52M+137% | $4.52M+64.6% | ||
| $139.07M+21.5% | $140.64M+18.5% | $131.87M+13.8% | $130.16M+13.8% | $114.47M+18.2% | ||
| $22.65M+680% | $37.2M+791% | $22.95M+90.9% | -$5.27M-214% | $2.9M+162% | ||
| $28.08M+240% | $42.49M+307% | $28.21M+57.7% | $221K-97.9% | $8.27M+785% | ||
| $28.08M+240% | $42.49M+307% | $28.21M+57.7% | $221K-97.9% | $8.27M+785% | ||
| 20.2%+13.0pp | 30.2%+21.4pp | 21.4%+5.9pp | 0.2%-8.9pp | 7.2%+6.3pp | ||
| $22.65M+680% | $37.2M+791% | $22.95M+90.9% | -$5.27M-214% | $2.9M+162% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Veracyte's profit margins?
- Gross margin is 70.9% and operating margin is 14.3%, with a 16.2% net margin.
- Where does Veracyte's income statement data come from?
- Every line is extracted from Veracyte's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.